Cargando…
COVID-19 off-label uses of medicines: the role of civil liability and regulation
Physicians can prescribe medicines for different indications than the tested and authorised ones. Such ‘off-label’ uses expand therapeutic options but also create uncertainties. The COVID-19 pandemic triggered new off-label uses and, despite issues being reported in the literature, these have not re...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Palgrave Macmillan UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196280/ https://www.ncbi.nlm.nih.gov/pubmed/37359236 http://dx.doi.org/10.1057/s41288-023-00302-z |